Home  »  Companies   »  What Did We Learn From DermTech Inc. (NASDAQ: DMTK...

What Did We Learn From DermTech Inc. (NASDAQ: DMTK) Insider Trading?

DermTech Inc. (NASDAQ:DMTK) traded at $5.50 at close of the session on Tuesday, 01/24/23, made a downward move of -1.61% on its previous day’s price.

Looking at the stock we see that its previous close was $5.59 and the beta (5Y monthly) reads 1.96 with the day’s price range being $5.2689 – $6.44. In terms of its 52-week price range, DMTK has a high of $16.33 and a low of $1.55. The company’s stock has gained about 202.20% over that past 30 days.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

DermTech Inc. has a market cap of $159.50 million and is expected to release its quarterly earnings report on Feb 27, 2023 – Mar 03, 2023. Estimates by analysts give the company expected earnings per share (EPS) of -$0.95, with the EPS growth for the year raised at -$3.97 for 2022 and -$3.7 for next year. These figures represent -46.50% and 6.80% growth in EPS for the two years respectively.

Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $4.97 million, with a low of $4.1 million and a high of $6.8 million. The median projection represents growth squeezing down to 45.70% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2022 is expected to hit $18.98 million, or 60.30% up from figures reported last year.

There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the DMTK stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of 50% Buy.

Looking further, we note the current price level is 83.67% off its SMA20 and 112.04% from its 50-day simple moving average. The RSI (14) is pointing at 72.20 while the volatility over the past week is 25.11% and jumps to 18.60% over the past one month. The beta value is 1.63, while the average true range (ATR) is currently pointing at 0.64.

Coming back to DermTech Inc. (NASDAQ:DMTK), we note that the average 3-month trading volume was 778.82K, while that of the preceding 10-day period stands at 1.82 million. Current shares outstanding are 30.10 million.

The insiders hold 2.30% of the company’s shares while institutions hold 43.40%. The data shows that short shares as of Oct 13, 2022, stood at 2.84 million at a short ratio of 6.71. This represents a 9.45% short interest in shares outstanding on Oct 13, 2022. Shares short fall in October from the previous month at 2.89 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 210.73% up in year-to-date price movement.

Leave a Comment

Your email address will not be published. Required fields are marked *